(Q41615761)

5 October 2017

1 reference

title

Treatment of organ transplant-related lymphoma (English)

1 reference

5 October 2017

L J Swinnen

1

1 reference

5 October 2017

publication date

1 October 1997

1 reference

Hematology / Oncology Clinics of North America

5 October 2017

published in

1 reference

5 October 2017

volume

11

1 reference

5 October 2017

issue

5

1 reference

5 October 2017

page(s)

963-973

1 reference

Lymphomas and lymphoproliferative lesions developing under cyclosporin therapy

5 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970473-1

7 January 2021

Monoclonality of lymphoproliferative lesions in cardiac-transplant recipients. Clonal analysis based on immunoglobulin-gene rearrangements

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970473-1

7 January 2021

Posttransplantation lymphoproliferative disorder in patients under primary tacrolimus (FK 506) immunosuppression

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970473-1

7 January 2021

Anti-B-cell monoclonal antibodies in the treatment of severe B-cell lymphoproliferative syndrome following bone marrow and organ transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970473-1

7 January 2021

Epstein-Barr virus-induced B-cell lymphoma after renal transplantation: acyclovir therapy and transition from polyclonal to monoclonal B-cell proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970473-1

7 January 2021

The frequency of Epstein-Barr virus infection and associated lymphoproliferative syndrome after transplantation and its manifestations in children

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970473-1

7 January 2021

Lymphoma development in mice and humans: diversity of initiation is followed by convergent cytogenetic evolution

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970473-1

7 January 2021

Lymphoproliferative disorders after organ transplantation: a report of 24 cases observed in a single center

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970473-1

7 January 2021

Clinical characteristics of post-transplant lymphoproliferative disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970473-1

7 January 2021

The diagnosis and treatment of posttransplant lymphoproliferative disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970473-1

7 January 2021

Incidence of non-Hodgkin lymphoma in kidney and heart transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970473-1

7 January 2021

Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970473-1

7 January 2021

Epstein-Barr-virus-induced oncogenesis in immune-deficient individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970473-1

7 January 2021

Expression of Epstein-Barr virus-encoded small RNA (by the EBER-1 gene) in liver specimens from transplant recipients with post-transplantation lymphoproliferative disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970473-1

7 January 2021

Early identification of Epstein-Barr virus-associated post-transplantation lymphoproliferative disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970473-1

7 January 2021

Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970473-1

7 January 2021

Treatment of B-cell lymphoproliferative disorders with interferon alfa and intravenous gamma globulin.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970473-1

7 January 2021

Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970473-1

7 January 2021

Increased incidence of lymphoproliferative disorder after immunosuppression with the monoclonal antibody OKT3 in cardiac-transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970473-1

7 January 2021

Pretransplantation assessment of the risk of lymphoproliferative disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970473-1

7 January 2021

Secondary cancers after bone marrow transplantation for leukemia or aplastic anemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970473-1

7 January 2021

Expression of Epstein-Barr virus transformation-associated genes in tissues of patients with EBV lymphoproliferative disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970473-1

7 January 2021

10.1016/S0889-8588(05)70473-1

Identifiers

DOI

1 reference

5 October 2017

1 reference